Drug Trial Radar · NCT07072195
A Study of AMC6156 in People With Sarcopenia
Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Jul 1, 2025
Primary completion
Oct 31, 2026
Study completion Feb 15, 2027
Sponsor
- Lead sponsor
- Animuscure Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial aims to find out whether AMC6156 can improve physical function and is safe in older adults with sarcopenia. Participants will take AMC6156 or a placebo daily for 12 weeks, and their movement, strength, and safety will be regularly monitored through tests and checkups.
Conditions
- Sarcopenia in Elderly
- Sarcopenia
Interventions
AMC6156 0.1mgDrug
Oral administration of AMC6156 in tablet form at a dose of 0.1 mg once daily for 12 weeks.
AMC6156 0.3mgDrug
Oral administration of AMC6156 in tablet form at a dose of 0.3 mg once daily for 12 weeks.
AMC6156 1.0mgDrug
Oral administration of AMC6156 in tablet form at a dose of 1.0 mg once daily for 12 weeks.
PlaceboDrug
Oral administration of placebo tablets matching AMC6156 in appearance, once daily for 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Short Physical Performance Battery (SPPB) Score from Baseline to Week 12Time frame: At Visit 1 (Screening), Visit 2 (Week 0, Baseline), Visit 3 (Week 4), Visit 4 (Week 8), and Visit 5 (Week 12)
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea · Recruiting
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea · Recruiting
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea · Recruiting
Seoul National University Hospital
Seoul, Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.